Cortexyme (CRTX) Stock Chart & Stock Price History $1.65 +0.01 (+0.61%) As of 10/3/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesTrendsBuy This Stock Cortexyme Stock Price Performance The Cortexyme (CRTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 109.26%, with a year-to-date return of -10.81%. In the past month, the stock has increased 2.80%, reflecting recent market activity. As of the latest close, Cortexyme traded at $1.64 with a market cap of $49.45 million and volume of 547,254 shares. Five years ago, the stock traded at $50.15, representing a 96.71% decrease over that period. At the time, it had a market cap of $1.48 billion and a volume of 64,771 shares. Receive CRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cortexyme and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+1.23%1 Month Performance+2.80%3 Month Performance+3.12%Year-To-Date Performance-10.81%1 Year Performance+109.26%5 Year Performance-96.71% CRTX Stock Chart for Monday, October, 6, 2025 CRTX Chart by TradingView Cortexyme Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/06/2025$1.65$1.65$1.70$1.63689,821 shs$49.75 million10/03/2025$1.62$1.64+1.23%$1.67$1.61547,254 shs$49.45 million10/02/2025$1.63$1.62-0.61%$1.68$1.61280,893 shs$48.85 million10/01/2025$1.61$1.63+1.24%$1.65$1.60246,291 shs$49.15 million09/30/2025$1.61$1.61$1.65$1.60322,351 shs$48.54 million09/29/2025$1.61$1.61$1.68$1.59390,145 shs$48.54 million09/26/2025$1.62$1.63+0.62%$1.67$1.60153,447 shs$49.15 million09/25/2025$1.61$1.62+0.62%$1.64$1.60162,394 shs$48.85 million09/24/2025$1.62$1.61-0.62%$1.64$1.58201,541 shs$48.54 million09/23/2025$1.60$1.62+1.25%$1.65$1.57245,627 shs$48.85 million Get the Latest News and Ratings for CRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cortexyme and its competitors with MarketBeat's FREE daily newsletter. 09/22/2025$1.60$1.60$1.63$1.58349,672 shs$48.24 million09/19/2025$1.61$1.61$1.66$1.60149,236 shs$48.54 million09/18/2025$1.62$1.61-0.62%$1.67$1.61142,370 shs$48.54 million09/17/2025$1.60$1.62+1.25%$1.65$1.60555,023 shs$48.85 million09/16/2025$1.60$1.60$1.62$1.5888,479 shs$48.24 million09/15/2025$1.60$1.60$1.62$1.58133,052 shs$48.24 million09/12/2025$1.61$1.58-1.86%$1.67$1.56222,267 shs$47.64 million09/11/2025$1.61$1.61$1.67$1.61120,760 shs$48.54 million09/10/2025$1.57$1.61+2.55%$1.66$1.56139,081 shs$48.54 million09/09/2025$1.61$1.57-2.48%$1.62$1.57127,622 shs$47.34 million09/08/2025$1.61$1.61$1.63$1.5788,853 shs$48.54 million09/05/2025$1.61$1.61-0.31%$1.65$1.57134,170 shs$48.39 million Related Companies Omnicell Stock Price Chart HealthStream Stock Price Chart Veradigm Stock Price Chart Protalix BioTherapeutics Stock Price Chart Inhibikase Therapeutics Stock Price Chart Invizyne Technologies Stock Price Chart CEL-SCI Stock Price Chart ZIVO Bioscience Stock Price Chart JATT Acquisition Stock Price Chart AlloVir Stock Price Chart Receive CRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cortexyme and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CRTX) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A Millionaire With SEVEN Clicks? $1,000 in just seven stocks in 2004 could have turned into a million-dolla...The Oxford Club | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cortexyme, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cortexyme With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
